Muncy Columbia Financial posts Q3 2026 net income $6.04M; EPS $0.57

Muncy Columbia Financial reported Q3 2026 net income of $6.04M, or $0.57 per share, down from $6.72M, or $0.63 per share, in Q3 2025. Net interest income rose to $17.63M, while non-interest income fell due to $2.4M losses on debt securities. The company declared a $0.155 per share dividend and had a book value per share of $18.18.

Original reporting
Published Oct 19, 2026, 7:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 7:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Muncy Columbia Financial posts Q3 2026 net income $6.04M; EPS $0.57 — source image
Decision brief

The 30-second read

$CCFNBearishMed
01

Why it matters

The earnings decline and realized losses on securities may prompt short‑term price weakness, but the recent stock split could support liquidity.

02

Market read

Micro‑cap earnings release with modest downside, limited broader market effect.

03

What to watch

The three‑for‑one stock split earlier in the year may attract new retail interest despite the earnings decline.

Relevance 6/10Novelty 6/10Timing: post‑market release

Background

Muncy Columbia Financial is a community bank that filed its Q3 2026 earnings via an 8‑K filing.

Company-level read

Ticker impact

$CCFNBearishMedium confidence
Context

Muncy Columbia Financial reported Q3 2026 net income of $6.04M and EPS of $0.57, down from the prior year.

Expected impact

likely downward pressure as the market prices in the earnings miss and loss on securities

Evidence & confidence

EPS fell 9.5% YoY and non‑interest income was negative due to realized losses, which typically weigh on the stock.

Market effects

Banking sector may see modest pressure as small‑cap lenders report earnings weakness.

Limited to U.S. regional banks and community lenders.

Low global impact; primarily a micro‑cap U.S. stock.

Counterpoint

If the stock has been oversold, the earnings miss could be a buying opportunity for value hunters.

Key entities

  • Muncy Columbia Financial Corp

    U.S. community bank reporting Q3 2026 results.

Related articles

$CCFNMed

Muncy Columbia Financial Corporation Announces Third Quarter 2026 Earnings

MUNCY COLUMBIA FINANCIAL Corp (CCFN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Press Release – For Immediate Release October 19, 2026 Muncy Columbia Financial Corporation Announces Third Quarter 2026 Earnings Bloomsburg, PA – Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), parent company of Journey Bank (“Bank”), has release

$CCFNMed

Muncy Columbia Financial Corporation Announces Second Quarter 2026 Earnings

MUNCY COLUMBIA FINANCIAL Corp (CCFN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Press Release – For Immediate Release July 20, 2026 Muncy Columbia Financial Corporation Announces Second Quarter 2026 Earnings Bloomsburg, PA – Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), parent company of Journey

$MRCYMed

Mercury Systems 3Q 2026: Revenue $253.15M, EPS $0.21 — 10-Q Summary

Mercury Systems reported 3Q 2026 revenue of $253.15M, up 12.4% YoY, and net income of $13.09M, reversing a prior-year loss. Growth in radar and electronic warfare applications drove results, while C4I revenue declined. Gross margin improved to 35.2% from 27.9%. The company expects to recognize 46% of its $1.193B remaining performance obligations as revenue in the next 12 months.

$SNWVMed

Sanuwave Announces Q3 FY2026 Financial Results

SANUWAVE Health, Inc. (SNWV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sanuwave Announces Q3 FY2026 Financial Results Q3 2026 revenues were $8.6 million, down 24% from $11.3 million in Q3 2025. Q3 2026 gross margin was 77.3%, versus 77.6% in Q3 2025. GAAP operating loss was $1.1 million for Q3 2026 versus operating income of $0.9 millio

$CPIXHighAI 8/10

CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE

CUMBERLAND PHARMACEUTICALS INC (CPIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE $100 million Strategic Transaction Closed Plans to Submit New Drug Application for Ifetroban in DMD Top-Line Results Announced for Systemic Sclerosis Trial NASHVILLE, Tenn. (Nov. 10, 2026) – Cumberland

$ATROHighAI 8/10

Astronics shares tumble on soft fourth quarter revenue outlook

Astronics (ATRO) reported Q3 earnings of $1.08 per share, beating estimates, with revenue up 28.5% YoY to $271.7M. However, shares fell 11% on Q4 revenue guidance of $255M-$275M, below expectations. The company maintained its full-year 2026 revenue guidance. Aerospace segment sales hit a record $245.5M, with strong demand in inflight entertainment and connectivity.